Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Healthcare Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed... see more

Recent & Breaking News (TSX:PRN)

Four Year Follow-Up Data from Profound Medical's TACT Pivotal Clinical Trial Confirm Durable and Stable Positive Trends Following Treatment with TULSA-PRO® of Men with Localized Prostate Cancer

GlobeNewswire September 26, 2022

Profound Medical Announces Changes to its Commercial Organization to Support Continued Growth

GlobeNewswire September 15, 2022

Profound Medical to Participate in September Investor Conferences

GlobeNewswire September 6, 2022

Profound Medical (TSX:PRN) gives TULSA-PRO a reimbursement update

Brieanna McCutcheon  September 2, 2022

Profound Medical Provides TULSA-PRO® Reimbursement Update

GlobeNewswire September 2, 2022

Profound Medical Announces Second Quarter 2022 Financial Results

GlobeNewswire August 4, 2022

Profound Medical to Release Second Quarter 2022 Financial Results on August 4 - Conference Call to Follow

GlobeNewswire July 14, 2022

Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference

GlobeNewswire June 16, 2022

Profound Medical to Participate in the 2022 Jefferies Global Healthcare Conference

GlobeNewswire June 2, 2022

Profound Medical Annual and Special Meeting of Shareholders Voting Results

GlobeNewswire May 18, 2022

Profound Medical Clarifies Recent Insider Buying

GlobeNewswire May 18, 2022

TULSA-PRO® Was Front and Center at AUA2022

GlobeNewswire May 17, 2022

Profound Medical Announces First Quarter 2022 Financial Results

GlobeNewswire May 9, 2022

Profound Medical to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire April 25, 2022

Profound Medical to Release First Quarter 2022 Financial Results on May 9 - Conference Call to Follow

GlobeNewswire April 18, 2022

Profound Medical Announces Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire March 3, 2022

Profound Medical to Participate in March Investor Conferences

GlobeNewswire March 2, 2022

Profound Medical's TULSA-PRO® Now Compatible with GE Healthcare's 3T MRI Scanners

GlobeNewswire March 1, 2022

Profound Medical to Release Fourth Quarter and Full Year 2021 Financial Results on March 3 - Conference Call to Follow

GlobeNewswire February 10, 2022

Profound Medical to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference

GlobeNewswire February 8, 2022